Cleared Traditional

K251543 - Atellica® IM TSH3-Ultra II (TSH3ULII) (FDA 510(k) Clearance)

Feb 2026
Decision
262d
Days
Class 2
Risk

K251543 is an FDA 510(k) clearance for the Atellica® IM TSH3-Ultra II (TSH3ULII). This device is classified as a Radioimmunoassay, Thyroid-stimulating Hormone (Class II - Special Controls, product code JLW).

Submitted by Siemens Healthcare Diagnostics, Inc. (Tarrytown, US). The FDA issued a Cleared decision on February 6, 2026, 262 days after receiving the submission on May 20, 2025.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1690.

Submission Details

510(k) Number K251543 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 20, 2025
Decision Date February 06, 2026
Days to Decision 262 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JLW — Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1690

Similar Devices — JLW Radioimmunoassay, Thyroid-stimulating Hormone

Dimension LOCI Thyroid Stimulating Hormone Flex reagent cartridge (TSHL)
K243570 · Siemens Healthcare Diagnostics · Apr 2025
ADVIA Centaur® TSH3-Ultra II (TSH3ULII)
K233050 · Siemens Healthcare Diagnostics, Inc. · Apr 2024
Atellica® CI Analyzer, Atellica® IMThyroid Stimulating Hormone 3-Ultra (TSH3-UL), Atellica® CH Albumin BCP (AlbP)
K222116 · Siemens Healthcare Diagnostics, Inc. · Jul 2023
Access TSH (3rd IS) Assay, DxI 9000 Access Immunoassay Analyzer
K221225 · Beckman Coulter, Inc. · Nov 2022